F. A. Pulatova

1 ta ish

Tashkent Pharmaceutical institute, Mirabad district, Aybek str., 45, Tashkent, 100015, Uzbekistan

1. Crystal structures of ( <i>S</i> )-3-{1-[(4-chlorophenyl)sulfonyl]piperidin-2-yl}pyridine, ( <i>S</i> )-3-[1-(4-methylphenyl)piperidin-2-yl]pyridine, ( <i>S</i> )-3-{1-[(4-methoxyphenyl)sulfonyl]piperidin-2-yl}pyridine and ( <i>S</i> )-3-{1-[(3,4-dimethylphenyl)sulfonyl]piperidin-2-yl}pyridine

   R.Ya. Okmanov, M.I. Olimova, I. E. Yuldashova +2

   MaqolaSulfur-Based Synthesis TechniquesActa Crystallographica Section E Crystallographic Communications20260 iqtibos

   ABIABI:AkademIndex/openalex/2026.article.015923